New Key Statistics Module, Z-Score and F-Score
SZSE:301239 Key Ratios
Market Cap ¥ M | 7,265.50 |
Enterprise Value ¥ M | 8,474.72 |
P/E(ttm) | 59.95 |
PE Ratio without NRI | 58.51 |
Forward PE Ratio | -- |
Price/Book | 3.19 |
Price/Sales | 2.68 |
Price/Free Cash Flow | 1,011.68 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.12 |
Revenue (TTM) ¥ M | 2,743.00 |
EPS (TTM) ¥ | 0.81 |
Beneish M-Score | -2.88 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 39.90 |
y-y EBITDA Growth Rate % | -2.90 |
EV-to-EBIT | 29.38 |
EV-to-EBITDA | 29.38 |
PEG | 1.47 |
Shares Outstanding M | 149.62 |
Net Margin (%) | 4.46 |
Operating Margin % | 11.78 |
Pre-tax Margin (%) | 7.65 |
Quick Ratio | 1.31 |
Current Ratio | 1.52 |
ROA % (ttm) | 2.67 |
ROE % (ttm) | 5.34 |
ROIC % (ttm) | 5.60 |
Dividend Yield % | 0.20 |
Altman Z-Score | 2.86 |
SZSE:301239 Number of Guru Trades
SZSE:301239 Volume of Guru Trades
Gurus Latest Trades with SZSE:301239
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301239 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Bright Eye Hospital Co Ltd Insider Transactions
No Available Data